Galderma to buy ZO Skin Health for $1.5 billion

· Beauty & Fashion · Switzerland · United States

Swiss skincare group Galderma announced on Wednesday, October 14, that it has agreed to acquire California-based ZO Skin Health for an enterprise value of USD 1.5 billion (EUR 1.3 billion). Galderma has signed an agreement to acquire 100% of the dermatological skincare company, strengthening its position in medicalized skincare. ZO Skin Health is a US brand built around physician-dispensed dermatological products, a segment where prescription-adjacent skincare and clinic channels have been growing faster than mass beauty. The deal hands Galderma a larger US footprint in doctor-led skincare and adds a brand that competes directly with other physician-channel players. It is a cash-intensive bet that medical skincare, not mass cosmetics, will keep taking share as consumers trade up to clinical claims.

Why it matters：The deal consolidates the fast-growing physician-dispensed skincare channel, pushing larger beauty groups to compete for clinical brands and raising valuations across derm-focused assets.

Key points

  • Enterprise value of USD 1.5 billion, or EUR 1.3 billion
  • Galderma signed to acquire 100% of the California dermatological skincare company
  • Announced Wednesday, October 14

Sources (original reporting)

More stories from this day